MapLight Therapeutics, Inc. (MPLT)
12.97
+0.37
(+2.94%)
USD |
NASDAQ |
Aug 31, 16:00
13.02
+0.05
(+0.39%)
After-Hours: 20:00
MapLight Therapeutics Cash from Operations (Annual) : -138.14M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -138.14M |
| December 31, 2024 | -78.82M |
| Date | Value |
|---|---|
| December 31, 2023 | -52.01M |
| December 31, 2022 | -26.58M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Evommune, Inc. | -76.44M |
| Sarepta Therapeutics, Inc. | -222.54M |
| Cullinan Therapeutics, Inc. | -175.75M |
| Mineralys Therapeutics, Inc. | -142.42M |
| Apogee Therapeutics, Inc. | -227.45M |